Combining surveillance systems to investigate local trends in tuberculosis-HIV co-infection

References

• Albalak, R., O'Brien, R. J., Kammerer, J. S., O'Brien, S. M., Marks, S. M., Castro, K. G., & Moore, M. (2007). Trends in tuberculosis/human immunodeficiency virus comorbidity, United States, 1993–2004. Archives of Internal Medicine, 167(22), 2443–2452. doi: 10.1001/archinte.167.22.2443
   PubMedGoogle Scholar
• California Department of Finance. (2012). E-4 population estimates for cities, counties, and the state, 2001–2010, with 2000 & 2010 census counts. Sacramento: California Department of Finance.
   Google Scholar
• California Department of Finance. (2017). E-4 population estimates for cities, counties, and the state, 2011–2017 with 2010 census benchmark. Sacramento: California Department of Finance.
   Google Scholar
• California Department of Public Health. (2001). Report on tuberculosis in California, 2000. Richmond: California Department of Public Health, Tuberculosis Control Branch.
   Google Scholar
• California Department of Public Health. (2008). Report on tuberculosis in California, 2007. Richmond: California Department of Public Health, Tuberculosis Control Branch.
   Google Scholar
• California Department of Public Health. (2009). Report on tuberculosis in California, 2008. Richmond: California Department of Public Health, Tuberculosis Control Branch.
   Google Scholar
• California Department of Public Health. (2012). Report on tuberculosis in California, 2011. Richmond: California Department of Public Health, Tuberculosis Control Branch.
   Google Scholar
• California Department of Public Health. (2014). Guide to HIV surveillance in California, version 3.5. Sacramento: California Department of Public Health, Office of AIDS.
   Google Scholar
• California Department of Public Health. (2016a). California HIV surveillance report — 2014. Sacramento: California Department of Public Health, Office of AIDS.
   Google Scholar
• California Department of Public Health. (2016b). Report on tuberculosis in California, 2015. Richmond: California Department of Public Health, Tuberculosis Control Branch.
   Google Scholar
• California Department of Public Health. (2017). Report on tuberculosis in California, 2016. Richmond: California Department of Public Health, Tuberculosis Control Branch.
   Google Scholar
• Campbell, K. M., Deck, D., & Krupski, A. (2008). Record linkage software in the public domain: A comparison of Link Plus, The Link King, and a ‘basic’ deterministic algorithm. Health Informatics Journal, 14(1), 5–15. doi: 10.1177/1460458208088855
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. (2009). CDC tuberculosis surveillance data training: Report of verified case of tuberculosis (RVCT) instruction manual. Atlanta, GA: US Department of Health and Human Services, CDC.
   Google Scholar
• Centers for Disease Control and Prevention. (2016). Reported tuberculosis in the United States, 2015. Atlanta, GA: US Department of Health and Human Services, CDC.
   Google Scholar
• Centers for Disease Control and Prevention. (2017). Reported tuberculosis in the United States, 2016. Atlanta, GA: US Department of Health and Human Services, CDC.
   Google Scholar
• Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., & Fleming, T. R. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365(6), 493–505. doi: 10.1056/NEJMoa1105243
   PubMed Web of Science ®Google Scholar
• Fiebig, L., Kollan, C., Hauer, B., Gunsenheimer-Bartmeyer, B., An der Heiden, M., Hamouda, O., & & Haas, W. (2012). HIV-prevalence in tuberculosis patients in Germany, 2002–2009: An estimation based on HIV and tuberculosis surveillance data. PLoS One, 7(11), e49111. doi: 10.1371/journal.pone.0049111
   PubMed Web of Science ®Google Scholar
• Grinsztejn, B., Hosseinipour, M. C., Ribaudo, H. J., Swindells, S., Eron, J., Chen, Y. Q., & Cohen, M. S. (2014). Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: Results from the phase 3 HPTN 052 randomised controlled trial. The Lancet Infectious Diseases, 14(4), 281–290. doi: 10.1016/S1473-3099(13)70692-3
   PubMed Web of Science ®Google Scholar
• HIV Epidemiology & Surveillance Unit. (2017). HIV in Alameda County, 2013–2015. Oakland, CA: Alameda County Public Health Department.
   Google Scholar
• Horsburgh, C. R., Jr. (2004). Priorities for the treatment of latent tuberculosis infection in the United States. New England Journal of Medicine, 350(20), 2060–2067. doi: 10.1056/NEJMsa031667
   PubMed Web of Science ®Google Scholar
• Kaplan, J. E., Benson, C., Holmes, K. K., Brooks, J. T., Pau, A., & Masur, H. (2009). Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from CDC, the national Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR. Recommendations and Reports, 58(RR04), 1–198.
   Google Scholar
• Kong, D., Watt, J. P., Marks, S. M., & Flood, J. M. (2014). Timely HIV diagnosis and HIV/TB comanagement among California patients in 2008. Public Health Reports, 129(2), 170–177. doi: 10.1177/003335491412900211
   PubMed Web of Science ®Google Scholar
• Lawn, S. D., Myer, L., Edwards, D., Bekker, L. G., & Wood, R. (2009). Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS, 23(13), 1717–1725. doi: 10.1097/QAD.0b013e32832d3b6d
   PubMed Web of Science ®Google Scholar
• Marcy, O., Laureillard, D., Madec, Y., Chan, S., Mayaud, C., Borand, L., & Blanc, F. X. (2014). Causes and determinants of mortality in HIV-infected adults with tuberculosis: An analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial. Clinical Infectious Diseases, 59(3), 435–445. doi: 10.1093/cid/ciu283
   PubMed Web of Science ®Google Scholar
• Martinson, N. A., Barnes, G. L., Moulton, L. H., Msandiwa, R., Hausler, H., Ram, M., & Chaisson, R. E. (2011). New regimens to prevent tuberculosis in adults with HIV infection. New England Journal of Medicine, 365(1), 11–20. doi: 10.1056/NEJMoa1005136
   PubMed Web of Science ®Google Scholar
• Metcalfe, J. Z., Porco, T. C., Westenhouse, J., Damesyn, M., Facer, M., Hill, J., & Flood, J. (2013). Tuberculosis and HIV co-infection, California, USA, 1993–2008. Emerging Infectious Diseases, 19(3), 400–406.
   PubMed Web of Science ®Google Scholar
• Pascopella, L., Barry, P. M., Flood, J., & DeRiemer, K. (2014). Death with tuberculosis in California, 1994–2008. Open Forum Infectious Diseases, 1(3), ofu090. doi: 10.1093/ofid/ofu090
   PubMedGoogle Scholar
• Podany, A. T., Bao, Y., Swindells, S., Chaisson, R. E., Andersen, J. W., Mwelase, T., & Fletcher, C. V. (2015). Efavirenz pharmacokinetics and pharmacodynamics in HIV-infected persons receiving rifapentine and isoniazid for tuberculosis prevention. Clinical Infectious Diseases, 61(8), 1322–1327. doi: 10.1093/cid/civ464
   PubMed Web of Science ®Google Scholar
• Reaves, E. J., Shah, N. S., France, A. M., Morris, S. B., Kammerer, S., Skarbinski, J., & Bradley, H. (2017). Latent tuberculous infection testing among HIV-infected persons in clinical care, United States, 2010–2012. The International Journal of Tuberculosis and Lung Disease, 21(10), 1118–1126. doi: 10.5588/ijtld.17.0041
   PubMed Web of Science ®Google Scholar
• Shea, K. M., Kammerer, J. S., Winston, C. A., Navin, T. R., & Horsburgh, C. R., Jr. (2014). Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup. American Journal of Epidemiology, 179(2), 216–225. doi: 10.1093/aje/kwt246
   PubMed Web of Science ®Google Scholar
• Sterling, T. R., Scott, N. A., Miro, J. M., Calvet, G., La Rosa, A., Infante, R., & Villarino, M. E. (2016). Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons. AIDS, 30(10), 1607–1615. doi: 10.1097/QAD.0000000000001098
   PubMed Web of Science ®Google Scholar
• Stout, J. E., Katrak, S., Goswami, N. D., Norton, B. L., Fortenberry, E. R., Foust, E., & Leone, P. A. (2014). Integrated screening for tuberculosis and HIV in tuberculosis contact investigations: Lessons learned in North Carolina. Public Health Reports, 129(Suppl. 1), 21–25. doi: 10.1177/00333549141291S104
   PubMedGoogle Scholar
• US Census Bureau. (2017). Annual estimates of the resident population by sex, race alone or in combination, and Hispanic origin for the United States, states, and counties: April 1, 2010 to July 1, 2016. Washington, DC: US Census Bureau, Population Division.
   Google Scholar
• van der Werf, M. J., Kodmon, C., Zucs, P., Hollo, V., Amato-Gauci, A. J., & Pharris, A. (2016). Tuberculosis and HIV coinfection in Europe: Looking at one reality from two angles. AIDS, 30(18), 2845–2853. doi: 10.1097/QAD.0000000000001252
   PubMed Web of Science ®Google Scholar
• Weiner, M., Egelund, E. F., Engle, M., Kiser, M., Prihoda, T. J., Gelfond, J. A., & Peloquin, C. A. (2014). Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers. Journal of Antimicrobial Chemotherapy, 69(4), 1079–1085. doi: 10.1093/jac/dkt483
   PubMed Web of Science ®Google Scholar
• Xia, Q., Westenhouse, J. L., Schultz, A. F., Nonoyama, A., Elms, W., Wu, N., & Flood, J. M. (2011). Matching AIDS and tuberculosis registry data to identify AIDS/tuberculosis comorbidity cases in California. Health Informatics Journal, 17(1), 41–50. doi: 10.1177/1460458210380524
   PubMed Web of Science ®Google Scholar
• Zou, G. (2004). A modified poisson regression approach to prospective studies with binary data. American Journal of Epidemiology, 159(7), 702–706. doi: 10.1093/aje/kwh090
   PubMed Web of Science ®Google Scholar